Drug Trends Part Three: Evaluating Opioids

Each year the Mitchell Pharmacy Solutions Drug Trends Series analyzes the state of pharmacy trends in workers' comp. In part three of our series, we’re evaluating the opioid therapeutic class.

Infographic Summary

Opioids continue to represent a decreasing proportion of overall scripts and costs, with favorable trends seen in important markers such as morphine equivalent dose (MED), duration of use, and access to guideline-supported measures including medication-assisted treatment (MAT) and overdose rescue medication (naloxone). Find out more in part three of our infographic series.

If you missed any of our drug trends series, be sure to visit the drug trends page for previous reports, short videos, and more.

View this and future installments of our drug trends series here.



To view future installments of our drug trends series, click here.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.

More from Risk & Insurance

More from Risk & Insurance